Improved risk stratification in myeloma using a microRNA-based classifier-Reference-Cited by-同舟云学术

Improved risk stratification in myeloma using a microRNA-based classifier

Published:2013-05-30 Issue:3 Volume:162 Page:348-359
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Wu Ping¹,Agnelli Luca,Walker Brian A.¹,Todoerti Katia,Lionetti Marta,Johnson David C.¹,Kaiser Martin¹,Mirabella Fabio¹,Wardell Christopher¹,Gregory Walter M.²,Davies Faith E.¹,Brewer Daniel³,Neri Antonino,Morgan Gareth J.¹

Affiliation:

1. Section of Haemato-Oncology; Institute of Cancer Research; Sutton; Surrey; UK

2. Clinical Trials Research Unit; University of Leeds; Leeds; UK

3. Prostate Cancer Genome Team; Institute of Cancer Research; Sutton; Surrey; UK

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12394/fullpdf

Reference58 articles.

1. Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation;Bagga;Cell,2005

2. Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma;Bergsagel;Blood,2005

3. TGF-beta and cancer;Bierie;Cytokine & Growth Factor Reviews,2006

4. A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial;Boyd;Leukemia,2012

5. MicroRNA signatures in human cancers;Calin;Nature Reviews Cancer,2006a

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating the clinical landscape: Update on the diagnostic and prognostic biomarkers in multiple myeloma;Molecular Biology Reports;2024-09-09

2. Epigenetic modification of miRNA in cancer;Personalized Epigenetics;2024

3. Dysregulation of Non-Coding RNAs: Roles of miRNAs and lncRNAs in the Pathogenesis of Multiple Myeloma;Non-Coding RNA;2023-11-03

4. miRNAs driving diagnosis, progression, and drug resistance in multiple myeloma;Pathology - Research and Practice;2023-08

5. Clinical Significance of microRNAs in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation;Cancers;2023-05-08